nei THIS MONTH IN
PSYCHOPHARMACOLOGY
Browsing articles in "Anxiety/Stress-Related Disorders"

 

Treatment With Propranolol Before Trauma Memory Reactivation May Reduce PTSD Symptoms
February 4, 2018   

Researcher found that trauma memory reactivation under the influence of propranolol showed a substantial reduction in posttraumatic stress disorder (PTSD) symptoms...
 Continue reading (Members only)
Combination Therapy Most Effective For Severe Pediatric Anxiety
October 23, 2017   

A recent secondary analysis of the Child/Adolescent Anxiety Multimodal Study (CAMS) was conducted to investigate predictors and moderators of pediatric anxiety...
 Continue reading (Members only)
Do Anxiety Disorders During Pregnancy Increase Risk of Adverse Birth Outcomes?
October 13, 2017   

The decision to treat mental health conditions, such as anxiety disorders, during pregnancy is an important and personal one; the health of the mother must be carefully weighed against potential adverse outcomes to the fetus. A recently published study adds valuable data on which such decisions can be informed....
 Continue reading (Members only)
Meta-Analysis: What Treatments Are Safe and Effective in Pediatric Anxiety?
September 18, 2017   

A recent meta-analysis compared the effectiveness of cognitive behavioral therapy (CBT) and pharmacotherapy for childhood anxiety disorders...
 Continue reading (Members only)
SSRIs, SNRIs Show Small But Significant Benefit for Children and Adolescents With Common Mental Illnesses
September 11, 2017   

There continues to be much debate over the utility and risk-to-benefit ratio of antidepressant use within the pediatric population. In the present meta-analysis, Locher and colleagues investigated the safety and efficacy of selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs)...
 Continue reading
Using Brain Patterns to Predict Treatment Response in PTSD
August 18, 2017   

In a recent study, patients with posttraumatic stress disorder (PTSD) underwent functional magnetic resonance imaging (fMRI) while completing three tasks assessing emotional reactivity and regulation...
 Continue reading (Members only)
Pediatric Suicide: Age Matters
June 20, 2017   

In the United States, the 4th leading cause of death among children age 5-14 years is suicide. In this study, Peyre and colleagues compared risk factors for suicide attempt in children and adolescents...
 Continue reading
FDA Approves Trials for MDMA as Treatment for PTSD
December 14, 2016   

As many as 24.5% of Iraq and Afghanistan veterans may suffer with posttraumatic stress disorder (PTSD), a disorder characterized by re-experiencing, avoidance, arousal, and changes to mood and cognition. Available pharmacological treatments approved for treating PTSD (sertraline and paroxetine) have very limited efficacy...
 Continue reading
FDA Alert: Boxed Warning for Combined Use of Opioids and Benzodiazepines
September 2, 2016   

The US FDA is added a boxed warning to the labels of opioid pain and opioid cough medications and benzodiazepines regarding the increased risk of central nervous system (CNS) depressant effects when these medications are used together...
 Continue reading (Members only)
Alert: Counterfeit Alprazolam
August 24, 2016   

US experts warn that counterfeit versions of the benzodiazepine alprazolam (Xanax, Pharmacia and Upjohn) that contain the highly potent opioid fentanyl are being sold online, placing people at risk for serious adverse events, including death...
 Continue reading (Members only)
12
Top of Page